BACKGROUND: To determine the prevalence of HIV and hepatitis C virus (HCV) infections and examine risk factors for these infections among inmates in Quebec provincial prisons. METHODS: Anonymous cross-sectional data were collected from January to June 2003 for men (n = 1357) and women (n = 250) who agreed to participate in the study and who completed a self-administrated questionnaire and provided saliva samples. RESULTS: The prevalence of HIV infection was 2.3% among the male participants and 8.8% among the female participants. The corresponding prevalence of HCV infection was 16.6% and 29.2%, respectively. The most important risk factor was injection drug use. The prevalence of HIV infection was 7.2% among the male injection drug users and 0.5% among the male non-users. Among the women, the rate was 20.6% among the injection drug users, whereas none of the non-users was HIV positive. The prevalence of HCV infection was 53.3% among the male injection drug users and 2.6% among the male non-users; the corresponding values among the women were 63.6% and 3.5%. INTERPRETATION: HIV and HCV infections constitute an important public health problem in prison, where the prevalence is affected mainly by a high percentage of injection drug use among inmates.
BACKGROUND: To determine the prevalence of HIV and hepatitis C virus (HCV) infections and examine risk factors for these infections among inmates in Quebec provincial prisons. METHODS: Anonymous cross-sectional data were collected from January to June 2003 for men (n = 1357) and women (n = 250) who agreed to participate in the study and who completed a self-administrated questionnaire and provided saliva samples. RESULTS: The prevalence of HIV infection was 2.3% among the male participants and 8.8% among the female participants. The corresponding prevalence of HCV infection was 16.6% and 29.2%, respectively. The most important risk factor was injection drug use. The prevalence of HIV infection was 7.2% among the male injection drug users and 0.5% among the male non-users. Among the women, the rate was 20.6% among the injection drug users, whereas none of the non-users was HIV positive. The prevalence of HCV infection was 53.3% among the male injection drug users and 2.6% among the male non-users; the corresponding values among the women were 63.6% and 3.5%. INTERPRETATION: HIV and HCV infections constitute an important public health problem in prison, where the prevalence is affected mainly by a high percentage of injection drug use among inmates.
Authors: Michel Alary; Jean R Joly; Jean Vincelette; René Lavoie; Bruno Turmel; Robert S Remis Journal: Am J Public Health Date: 2005-03 Impact factor: 9.308
Authors: A King; S A Marion; D Cook; M Rekart; P J Middleton; M V O'Shaughnessy; J S Montaner Journal: J Acquir Immune Defic Syndr Hum Retrovirol Date: 1995-06-01
Authors: Rena K Fox; Sue L Currie; Jennifer Evans; Teresa L Wright; Leslie Tobler; Bruce Phelps; Michael P Busch; Kimberly A Page-Shafer Journal: Clin Infect Dis Date: 2005-06-09 Impact factor: 9.079
Authors: Marisol Peña-Orellana; Adriana Hernández-Viver; Glorimar Caraballo-Correa; Carmen E Albizu-García Journal: J Health Care Poor Underserved Date: 2011-08
Authors: Ryan Van Meer; Tony Antoniou; Daniel McCormack; Sumeet Khanna; Claire Kendall; Lori Kiefer; Fiona G Kouyoumdjian Journal: Can J Public Health Date: 2019-06-27
Authors: Margaret Erickson; Kate Shannon; Ariel Sernick; Neora Pick; Flo Ranville; Ruth E Martin; Andrea Krüsi Journal: AIDS Date: 2019-01-27 Impact factor: 4.177
Authors: Arthur Y Kim; Ellen H Nagami; Christopher E Birch; Melinda J Bowen; Georg M Lauer; Barbara H McGovern Journal: Hepatology Date: 2013-02-15 Impact factor: 17.425